Publications

Endogenous opioids regulate glucocorticoid-dependent stress-coping strategies in mice. Klaudia Szklarczyk, Michal Korostynski, Slawomir Golda, Marcin Piechota, Joanna Ficek, Ryszard Przewlocki
Neuroscience, 10.1016/j.neuroscience.2016.05.034 S0306-4522(16)30193-2
PMID:27235740
Wednesday, 29 June 2016
GPCRdb: the G protein-coupled receptor database - an introduction. C Munk, V Isberg, S Mordalski, K Harpsøe, K Rataj, A S Hauser, P Kolb, A J Bojarski, G Vriend, D E Gloriam
British journal of pharmacology, 10.1111/bph.13509
PMID:27155948
Friday, 24 June 2016
Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland. Paweł Kawalec, Krzysztof Piotr Malinowski, Andrzej Pilc
Rheumatology international, 10.1007/s00296-016-3514-3
PMID:27339273
Thursday, 23 June 2016
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats. Karolina Podkowa, Bartłomiej Pochwat, Piotr Brański, Andrzej Pilc, Agnieszka Pałucha-Poniewiera
Psychopharmacology, 10.1007/s00213-016-4325-7
PMID:27286960
Saturday, 11 June 2016
NMDA Receptors on Dopaminoceptive Neurons Are Essential for Drug-Induced Conditioned Place Preference. Magdalena Sikora, Krzysztof Tokarski, Bartosz Bobula, Joanna Zajdel, Kamila Jastrzębska, Przemysław Eligiusz Cieślak, Magdalena Zygmunt, Joanna Sowa, Magdalena Smutek, Katarzyna Kamińska, Krystyna Gołembiowska, David Engblom, Grzegorz Hess, Ryszard Przewlocki, Jan Rodriguez Parkitna
eNeuro, 10.1523/ENEURO.0084-15.2016 ENEURO.0084-15.2016
PMID:27294197
Thursday, 9 June 2016
An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity. Rafał Kurczab, Vittorio Canale, Paweł Zajdel, Andrzej J Bojarski
PloS one, 10.1371/journal.pone.0156986
PMID:27271158
Thursday, 9 June 2016
Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients. S Rzezniczek, M Obuchowicz, W Datka, M Siwek, D Dudek, K Kmiotek, K Oved, N Shomron, D Gurwitz, A Pilc
Translational psychiatry, 10.1038/tp.2016.90
PMID:27244236
Tuesday, 31 May 2016
Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice. Michael Fritz, Anna M Klawonn, Anna Nilsson, Anand Kumar Singh, Joanna Zajdel, Daniel Björk Wilhelms, Michael Lazarus, Andreas Löfberg, Maarit Jaarola, Unn Örtegren Kugelberg, Timothy R Billiar, David J Hackam, Chhinder P Sodhi, Matthew D Breyer, Johan Jakobsson, Markus Schwaninger, Günther Schütz, Jan Rodriguez Parkitna, Clifford B Saper, Anders Blomqvist, David Engblom
The Journal of clinical investigation,
PMID:26690700
Saturday, 28 May 2016
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile. Rafał R Jaeschke, Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, Krzysztof Styczeń, Wojciech Datka
Pharmacological reports : PR, S1734-1140(16)30020-2 10.1016/j.pharep.2016.04.002
PMID:27203278
Friday, 20 May 2016
The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Agnieszka Nikiforuk, Małgorzata Hołuj, Tomasz Kos, Piotr Popik
Neuropharmacology, 10.1016/j.neuropharm.2016.01.035 S0028-3908(16)30034-X
PMID:26826431
Thursday, 19 May 2016